Cargando…
Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis
BACKGROUND: The effects of gonadotrophin-releasing hormone agonist (GnRH-a) administered in the luteal phase remains controversial. This meta-analysis aimed to evaluate the effect of the administration of a single-dose of GnRH-a in the luteal phase on ICSI clinical outcomes. METHODS: The research st...
Autores principales: | Oliveira, João Batista A, Baruffi, Ricardo, Petersen, Cláudia G, Mauri, Ana L, Cavagna, Mario, Franco, José G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2942885/ https://www.ncbi.nlm.nih.gov/pubmed/20825643 http://dx.doi.org/10.1186/1477-7827-8-107 |
Ejemplares similares
-
GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012) -
Efficacy of daily GnRH agonist for luteal phase support following GnRH agonist triggered ICSI cycles versus conventional strategy: A Randomized controlled trial
por: Salehpour, Saghar, et al.
Publicado: (2021) -
Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial
por: Benmachiche, Abdelhamid, et al.
Publicado: (2017) -
GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
por: Alyasin, Ashraf, et al.
Publicado: (2016) -
Effect of Administration of Single Dose GnRH Agonist in Luteal Phase on Outcome of ICSI-ET Cycles in Women with Previous History of IVF/ICSI Failure: A Randomized Controlled Trial
por: Zafardoust, Simin, et al.
Publicado: (2015)